Jing Pan1, Lin Xu2, Tai Hing Lam3, Chao Qiang Jiang4, Wei Sen Zhang1, Ya Li Jin1, Feng Zhu1, Tong Zhu1, G Neil Thomas5, Kar Keung Cheng5, Peymane Adab5. 1. Guangzhou No.12 Hospital, Guangzhou, Guangdong, China. 2. School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong Province, China; School of Public Health, The University of Hong Kong, Hong Kong, China. 3. Guangzhou No.12 Hospital, Guangzhou, Guangdong, China; School of Public Health, The University of Hong Kong, Hong Kong, China. Electronic address: hrmrlth@hku.hk. 4. Guangzhou No.12 Hospital, Guangzhou, Guangdong, China. Electronic address: jcqianggz@163.com. 5. Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Abstract
OBJECTIVE: We examined the association between different adiposity indices and pulmonary function in Chinese adults in the Guangzhou Biobank Cohort Study (GBCS). METHODS: Participants with body mass index (BMI) < 18.5 (underweight) were excluded. Adiposity indices including BMI, waist circumference (WC), waist hip ratio, waist height ratio and body fat percentage were measured. Lung function was assessed by spirometry using a turbine flowmeter. We analyzed percent predicted for forced expiratory volume in 1 s (FEV1%), forced vital capacity (FVC %) and restrictive respiratory defect (FEV1/FVC ratio > low limits of normal and FVC % <0.80). RESULTS: Of 16186 participants (mean age 61.4 ± 7.2 years; 74.0% women), 116 (0.7%) had only general obesity (BMI ≥28 kg/m2), 4079 (25.2%) had only central obesity (WC: ≥90 cm in men, ≥80 cm in women) and 1591 (9.8%) had both central obesity and general obesity. Comparing to those with neither central nor general obesity, those with only central adiposity and with both central and general obesity had lower pulmonary function (adjusted β range from -2.85 to -6.02 for FEV1% and FVC%, adjusted OR range from 1.14 to 1.70, all P < 0.05). But those with only general obesity had better but non-significant pulmonary function. (Crude β range from 1.46 to 2.92 for FEV1% and FVC%, crude OR range from 0.68 to 0.93, all P > 0.05). Both FEV1% and FVC% decreased per standard deviation increase in obesity indices (adjusted β from -0.46 to -3.17, all P < 0.002). A positive association of central or general obesity with restrictive respiratory defect was observed (adjusted odds ratio (AOR) from 1.50 to 2.04, all P < 0.002). Further adjustment for WC reversed the inverse association between BMI and pulmonary function (adjusted β from 1.93 to 6.22, all P < 0.001) and restrictive respiratory defect (adjusted AOR from 0.72 to 0.80, all P < 0.001). CONCLUSION: Central adiposity and its indices, but not general adiposity and BMI, were independently associated with lower pulmonary function and higher risk of restrictive respiratory defect in older Chinese.
OBJECTIVE: We examined the association between different adiposity indices and pulmonary function in Chinese adults in the Guangzhou Biobank Cohort Study (GBCS). METHODS:Participants with body mass index (BMI) < 18.5 (underweight) were excluded. Adiposity indices including BMI, waist circumference (WC), waist hip ratio, waist height ratio and body fat percentage were measured. Lung function was assessed by spirometry using a turbine flowmeter. We analyzed percent predicted for forced expiratory volume in 1 s (FEV1%), forced vital capacity (FVC %) and restrictive respiratory defect (FEV1/FVC ratio > low limits of normal and FVC % <0.80). RESULTS: Of 16186 participants (mean age 61.4 ± 7.2 years; 74.0% women), 116 (0.7%) had only general obesity (BMI ≥28 kg/m2), 4079 (25.2%) had only central obesity (WC: ≥90 cm in men, ≥80 cm in women) and 1591 (9.8%) had both central obesity and general obesity. Comparing to those with neither central nor general obesity, those with only central adiposity and with both central and general obesity had lower pulmonary function (adjusted β range from -2.85 to -6.02 for FEV1% and FVC%, adjusted OR range from 1.14 to 1.70, all P < 0.05). But those with only general obesity had better but non-significant pulmonary function. (Crude β range from 1.46 to 2.92 for FEV1% and FVC%, crude OR range from 0.68 to 0.93, all P > 0.05). Both FEV1% and FVC% decreased per standard deviation increase in obesity indices (adjusted β from -0.46 to -3.17, all P < 0.002). A positive association of central or general obesity with restrictive respiratory defect was observed (adjusted odds ratio (AOR) from 1.50 to 2.04, all P < 0.002). Further adjustment for WC reversed the inverse association between BMI and pulmonary function (adjusted β from 1.93 to 6.22, all P < 0.001) and restrictive respiratory defect (adjusted AOR from 0.72 to 0.80, all P < 0.001). CONCLUSION: Central adiposity and its indices, but not general adiposity and BMI, were independently associated with lower pulmonary function and higher risk of restrictive respiratory defect in older Chinese.
Authors: Emily S Wan; Spyridon Fortis; Elizabeth A Regan; John Hokanson; MeiLan K Han; Richard Casaburi; Barry J Make; James D Crapo; Dawn L DeMeo; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2018-12-01 Impact factor: 30.528
Authors: Magnus Svartengren; Gui-Hong Cai; Andrei Malinovschi; Jenny Theorell-Haglöw; Christer Janson; Sölve Elmståhl; Lars Lind; Erik Lampa; Eva Lindberg Journal: ERJ Open Res Date: 2020-11-02
Authors: Yang Fuzhi; Tang Dongfang; Fu Wentao; Wang Jing; Wu Yingting; Mo Nianping; Gao Wen; Shen Xiaoyong Journal: Front Oncol Date: 2022-07-11 Impact factor: 5.738
Authors: Ian B Stanaway; Taryn O Hall; Elisabeth A Rosenthal; Melody Palmer; Vivek Naranbhai; Rachel Knevel; Bahram Namjou-Khales; Robert J Carroll; Krzysztof Kiryluk; Adam S Gordon; Jodell Linder; Kayla Marie Howell; Brandy M Mapes; Frederick T J Lin; Yoonjung Yoonie Joo; M Geoffrey Hayes; Ali G Gharavi; Sarah A Pendergrass; Marylyn D Ritchie; Mariza de Andrade; Damien C Croteau-Chonka; Soumya Raychaudhuri; Scott T Weiss; Matt Lebo; Sami S Amr; David Carrell; Eric B Larson; Christopher G Chute; Laura Jarmila Rasmussen-Torvik; Megan J Roy-Puckelwartz; Patrick Sleiman; Hakon Hakonarson; Rongling Li; Elizabeth W Karlson; Josh F Peterson; Iftikhar J Kullo; Rex Chisholm; Joshua Charles Denny; Gail P Jarvik; David R Crosslin Journal: Genet Epidemiol Date: 2018-10-08 Impact factor: 2.135